QUETIAPINE FOR THE TREATMENT OF DYSCINESIA IN NON PSYCHOTIC PATIENTS.

摘要

The use of quetiapine or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating dyskinesias associated with dopaminergic therapy of non-psychotic patients, characterized in that the dopaminergic agent is selected from levodopa, bromocriptine, pergolide and adamantine.